pharma
UCB Pharma’s bimekizumab improves skin clearance over Humira in plaque psoriasis
November 3, 2020Manufacturing and Production, Research and Development UCB Pharma, bimekizumab, pharma
In recent Phase 3 study data presented European Academy of Dermatology and Venereology Congress last weekend, UCB Pharma reported that …
Sanofi angles to buy Kiadis for €308 million
November 2, 2020Sales and Marketing Sanofi, kiadis, pharma
Sanofi has announced it is poised to buy out Amsterdam-based biopharma firm Kiadis in an all-cash public offer of €308 …
LEO Pharma’s delgocitinib hits main goals in moderate-to-severe chronic hand eczema
November 2, 2020Research and Development, Sales and Marketing LEO Pharma, eczema, pharma
LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Virtual 2020 Virtual Congress …
European Commission greenlights Insmed’s Arikayce for nontuberculous mycobacterial lung infections
October 29, 2020Sales and Marketing Arikayce, EU, lungs, pharma
The European Commission (EC) has given approval to Insmed Incorporated’s Arikayce (liposomal 590mg nebuliser dispersion) for the treatment of nontuberculous …
US reserves 300,000 doses of Lilly’s COVID-19 treatment in $375 million deal
October 28, 2020Manufacturing and Production, Research and Development, Sales and Marketing COVID-19, Eli Lilly, US, pharma
The US Government has signed a $375 million deal with Eli Lilly to buy 300,000 700mg doses of bamlanivimab, its …
The November 2020 issue of Pharmafocus is available to read free online now!
October 27, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Biden, Pharmafocus, Trump, UK, US election, brexit, pharma, remdesivir
The latest monthly edition of Pharmafocus is available to read for free online now!
Sanofi’s Dupixent shows strength at Phase 3 in eosinophilic esophagitis
October 27, 2020Manufacturing and Production Dupixent, Sanofi, pharma
Sanofi has lifted the curtain on new Phase 3 data for Dupixent (dupilumab), showing that the drug met all of …
Bayer buys out US-based Asklepios BioPharmaceutical in potential $4bn deal
October 26, 2020Sales and Marketing Asklepios, Bayer, acquisition, pharma
Bayer has moved to bolster its cell and gene therapy (CGT) business through the acquisition of US biotech Asklepios BioPharmaceutical …
Bayer’s Nubeqa secures NICE recommendation for hormone-relapsed prostate cancer at risk of metastasis
October 23, 2020Medical Communications, Sales and Marketing Bayer, NCIE, Nubeqa, pharma
NICE has given its recommendation to Bayer’s androgen receptor inhibitor Nubeqa (darolutamide) in combination with androgen deprivation therapy (ADT) for …
Gilead’s Biktarvy proves non-inferior to standard care for HIV in Black and African American patients
October 22, 2020Research and Development Biktarvy, Gilead, HIV, pharma
Gilead has revealed promising new Phase 3 data reinforcing the non-inferiority of Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg) compared to …
Eli Lilly refutes FDA quality concerns at New Jersey facility producing COVID-19 drug
October 21, 2020Manufacturing and Production, Research and Development COVID-19, Eli Lilly, FDA, pharma
Eli Lilly has rebutted reports of FDA quality assurance concerns at its manufacturing facility in Branchburg, New Jersey, where it …
New technology allows scientists to study the inside of cells using VR
October 20, 2020Manufacturing and Production, Research and Development VR, Virtual reality, pharma
New virtual reality software allows researchers to “walk” inside cells and analyse them up close in order to better understand …
New treatment could extend survival in amyotrophic lateral sclerosis patients
October 20, 2020Manufacturing and Production, Research and Development als, pharma
Research into an experimental drug combination shows that it could potentially extend the lives for sufferers of amyotrophic lateral sclerosis …
UK life sciences industry does not want no-deal Brexit, says ABPI Chief
October 19, 2020Sales and Marketing ABPI, EU, UK, brexit, pharma
Prime Minister Boris Johnson’s sudden change of position that the UK is now expecting a no-deal scenario with the European …
FDA approves Venclexta combo in acute myeloid leukaemia, despite it missing main study goal
October 19, 2020Sales and Marketing AbbVie, FDA, Roche, Venclexta, pharma
The FDA has given approval to AbbVie and Roche’s jointly-developed BCL-2 inhibitor Venclexta (venetoclax) in combination with azacitidine, decitabine, or low-dose …
